# MRI-visible Enlarged Perivascular Spaces and the Alteration of Lymphatic Drainage System in CAA

Study · id `cardio:ct-nct04604587` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04604587](<https://clinicaltrials.gov/study/NCT04604587>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04604587

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

## Technical summary

Registry record NCT04604587. Allocation not applicable; no masking; primary purpose diagnostic. Start 2020-10-08 (actual); primary completion 2023-07-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Phase 3
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT04604587, source copy `cardio:ctgov-nct04604587-2020-10-27`, retrieved 2026-10-31)
- Started: 2020-10-08 (actual) (ClinicalTrials.gov record NCT04604587, source copy `cardio:ctgov-nct04604587-2020-10-27`, retrieved 2026-10-31)
- Primary completion: 2023-07-31 (anticipated) (ClinicalTrials.gov record NCT04604587, source copy `cardio:ctgov-nct04604587-2020-10-27`, retrieved 2026-10-31)
- Completion: 2023-07-31 (anticipated) (ClinicalTrials.gov record NCT04604587, source copy `cardio:ctgov-nct04604587-2020-10-27`, retrieved 2026-10-31)
- Countries: Taiwan (ClinicalTrials.gov record NCT04604587, source copy `cardio:ctgov-nct04604587-2020-10-27`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04604587-2020-10-27`, retrieved 2026-10-31)

## The registry's words

- Brief title: MRI-visible Enlarged Perivascular Spaces and the Alteration of Lymphatic Drainage System in CAA
- Acronym: CAA
- Condition: Cerebral Amyloid Angiopathy
- Condition: Intracerebral Hemorrhage
- Intervention (Drug): 1. amyloid PET；2. T807 PET
- Lead sponsor: National Taiwan University Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Bleeding in the brain (intracerebral hemorrhage) (`cardio:intracerebral-hemorrhage`)
- Registry lists this organization as the lead sponsor: National Taiwan University Hospital (`cardio:org-national-taiwan-university-hospital`)

## Provenance

Content hash: 7038779d351f23e3d098638357006b513e1ed5e2e5f2a3863faaff2a61d5e88f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
